Tectonic Therapeutic, Inc. (TECX) — Financial statements
Income statement, balance sheet, and cash flow for Tectonic Therapeutic, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 63↑53.5% | 41↑11.9% | 37↑44.1% | 26↑133.7% | 11 | |
| General & Administrative Expenses | 21↑23.4% | 17↑116.8% | 8↑7.1% | 7↑54.9% | 5 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 21↑23.4% | 17↑116.8% | 8↑7.1% | 7↑54.9% | 5 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 84↑44.9% | 58↑29.9% | 45↑36.0% | 33↑110.3% | 16 | |
| Total Costs & Expenses | 84↑44.9% | 58↑29.9% | 45↑36.0% | 33↑110.3% | 16 | |
| Operating Results | ||||||
| Operating Income | -84↓44.9% | -58↓29.9% | -45↓36.0% | -33↓110.3% | -16 | |
| Depreciation & Amortization | 1↓16.4% | 2↑11.3% | 1↑46.9% | 1↑176.4% | 0.36 | |
| EBITDA | -71↓27.1% | -56↓36.5% | -41↓32.8% | -31↓282.2% | -8 | |
| EBIT | -73↓25.9% | -58↓35.6% | -43↓33.2% | -32↓277.7% | -8 | |
| Interest & Other Income | ||||||
| Net Interest Income | 11↑170.4% | 4↑868.3% | 0.43↑8480.0% | 0.01↑102.2% | -0.22 | |
| Interest Income | 11↑165.1% | 4↑633.4% | 0.58↑289.9% | 0.15 | 0.00 | |
| Interest Expense | 0.06↓41.1% | 0.11↓29.6% | 0.15↑5.6% | 0.14↓35.7% | 0.22 | |
| Non-Operating Income | -11↓7884.3% | -0.14↑92.9% | -2↓149.0% | -0.79↑88.9% | -7 | |
| Other Income / Expenses | 11↑33581.8% | 0.03↓98.2% | 2↑180.8% | 0.65↓90.3% | 7 | |
| Income Before Tax | -73↓25.8% | -58↓35.4% | -43↓33.1% | -32↓260.5% | -9 | |
| Income Tax Expense | 1 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -74↓27.9% | -58↓35.4% | -43↓33.1% | -32↓260.5% | -9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -74↓27.9% | -58↓35.4% | -43↓33.1% | -32↓260.5% | -9 | |
| Bottom-Line Net Income | -74↓27.9% | -58↓35.4% | -43↓33.1% | -32↓260.5% | -9 | |
| EPS (Basic) | -4.05↓3.1% | -3.93↑66.1% | -11.59↑60.1% | -29.05↑12.9% | -33.36 | |
| EPS (Diluted) | -4.05↓3.1% | -3.93↑65.9% | -11.53↑60.3% | -29.05↑12.9% | -33.36 | |
| Weighted Average Shares | 18↑24.1% | 15↑299.8% | 4↑1.3% | 4↑2.1% | 4 | |
| Weighted Average Diluted Shares | 18↑24.1% | 15↑297.6% | 4↑1.9% | 4↑2.1% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.